Neuphoria Therapeutics (NEUP) Operating Expenses (2023 - 2026)
Neuphoria Therapeutics (NEUP) reported Operating Expenses of $6.7 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 15.1% from $5.82 million a year earlier and up 453.0% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Operating Expenses (2023 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Neuphoria Therapeutics posted Operating Expenses of $17.63 million, up 5.0% from FY2025.
- Operating Expenses has a five-year compound annual growth rate of 31.8% (FY2021 to FY2026).
- By fiscal year, Operating Expenses came in at $16.78 million in FY2025 (-6.2%), $17.89 million in FY2024 (-18.6%), $21.98 million in FY2023 (+91.8%) and $11.46 million in FY2022 (+158.3%).
- The fiscal Q4 2026 figure ranks as the highest quarterly Operating Expenses in data going back to fiscal Q1 2024.
- Year over year, Operating Expenses gained in four of the last eight quarters, with an average year-over-year change of 0.0%.
- The high point for year-over-year Operating Expenses in five years was fiscal Q1 2026 (growth of 58.4%); the low point was fiscal Q3 2026 (a decline of 59.9%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $1.21 million (Q3 2026), $4.06 million (Q2 2026) and $5.65 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 6.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.70 Mn |
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 5.65 Mn |
| Jun 30, 2025 | 5.82 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 4.37 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 5.48 Mn |
| Mar 31, 2024 | 2.39 Mn |
| Dec 31, 2023 | 4.55 Mn |
| Sep 30, 2023 | 5.47 Mn |
API Access
Neuphoria Therapeutics Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();